Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies

Clinical trial NCT01110226 · TERMINATED

Trial details

NCT number: NCT01110226
Sponsor: University of Maryland, Baltimore
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer, Small Cell Lung Cancer Platinum Responsive Malignancies

Start date: 2010-04-27
Primary completion: 2015-10-22
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.